CS264721B1 - Hydrophilic emulsion cream - Google Patents

Hydrophilic emulsion cream Download PDF

Info

Publication number
CS264721B1
CS264721B1 CS872085A CS208587A CS264721B1 CS 264721 B1 CS264721 B1 CS 264721B1 CS 872085 A CS872085 A CS 872085A CS 208587 A CS208587 A CS 208587A CS 264721 B1 CS264721 B1 CS 264721B1
Authority
CS
Czechoslovakia
Prior art keywords
hydrophilic
emulsion cream
emulsion
aminotridecane
cream
Prior art date
Application number
CS872085A
Other languages
Czech (cs)
Slovak (sk)
Other versions
CS208587A1 (en
Inventor
Stefan Rndr Minczinger
Luboslav Pharmdr Razus
Edita Abs Farm Barankova
Jozef Ing Nevydal
Original Assignee
Minczinger Stefan
Luboslav Pharmdr Razus
Edita Abs Farm Barankova
Nevydal Jozef
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minczinger Stefan, Luboslav Pharmdr Razus, Edita Abs Farm Barankova, Nevydal Jozef filed Critical Minczinger Stefan
Priority to CS872085A priority Critical patent/CS264721B1/en
Publication of CS208587A1 publication Critical patent/CS208587A1/en
Publication of CS264721B1 publication Critical patent/CS264721B1/en

Links

Landscapes

  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

Riešenie sa týká hydrofilného emulzného krému, obsahujúceho v hydrofóbnej i hydrofilnej zložke zlúčeniny 2-aminotridekanu p&sobiace dezinfekčně, antimikrobiálne a antimykoticky, čím je zabezpečený povrchový i hlbkový účinok.The solution relates to a hydrophilic emulsion cream containing 2-aminotridecane compounds in the hydrophobic and hydrophilic components, which have a disinfecting, antimicrobial and antifungal effect, thereby ensuring both a superficial and a deep effect.

Description

264721 2264721 2

Vynález sa týká hydrofilného emulzného krému určeného najmH k mikrobiálněj ochraně po-kožky pracujúcich v polnohospodárstve, tažkom priemysle, chemickom priemysle, zdravotníctvea pod.BACKGROUND OF THE INVENTION The present invention relates to a hydrophilic emulsion cream designed especially for microbial skin protection in agriculture, heavy industry, chemical industry, and health.

Hydrofilné emulzné krémy patria medzi disperzně systémy emulzného typu, kde vodná fázatvoří vonkajšiu kontinuálnu část a hydrofóbňu fázu, ktorá je v nej rovnoměrně dispergovaná.Hydrophilic emulsion creams are emulsion type dispersion systems wherein the aqueous phase forms the outer continuous portion and the hydrophobic phase is uniformly dispersed therein.

Nazývajú sa emulzie olej vo vodě 0/V.They are called oil-in-water emulsions 0 / V.

Dezinfekčně krémy typu 0/V obsahujú vHčšinou účinná látku vo vodnej, to znamená vonkaj-šej fáze, která je v nej rozpustná, t. j. aktívna látka je nepřestupná lipofilnou bariéroukože a je účinná len povrchovo.Type 0 / V disinfectant creams typically contain the active ingredient in an aqueous, i.e., external phase, soluble therein, i.e., the active agent is non-permeable to the lipophilic barrier and is only superficially effective.

Príkladom sú ochranné pracovně emulzné krémy, ktoré obsahujú 2-aminotridekan kyslýadipát. Ďalšími účinnými látkami, ktoré sa používajú v tejto terapeutickéj oblasti sú napr.mucidín (Masák, Antimykotika, studijní správa č. 2 075, 1983, VOFB). Nevýhodou tejto látkyje nízká rozpustnost vo vodě a tým aj obmedzenie terapeutickéj použitelnosti.Examples are protective emulsion creams which contain 2-aminotridecane acid adipate. Other active compounds used in this therapeutic field are, for example, mucidine (Masak, Antimycotics, Study Report No. 2,075, 1983, VOFB). A disadvantage of this substance is its low water solubility and hence the limitation of therapeutic applicability.

Iným liečivom, ktoré sa používá externe je bifonazol (Plempel, M. Antimycotic efficacyof bifonazole in vitro and in vivo., Arzneim. Forsch. 33, 1983, 517-524). Jeho velkou nevý-hodou je nízký účinok proti kvasinkám.Another drug used externally is bifonazole (Plempel, M. Antimycotic efficacyof bifonazole in vitro and in vivo, Arzneim. Forsch. 33, 1983, 517-524). Its great disadvantage is its low anti-yeast effect.

Podobné nízký antibakteriálny účinok sa našiel u imazalilu (Thienpont, D., The biologicaland toxicological properties of imazalil. Arzneim. Forsch., 31, 1981, 309-315).A similar low antibacterial effect was found with imazalil (Thienpont, D., The Biological Biochemical Properties of Imazalil. Arzneim. Forsch., 31, 1981, 309-315).

Hydrofilný emulzný krém podlá předmětného vynálezu rieši tieto nedostatky tým, že v hyd-rofóbnej časti emulzie je rozpuštěný 2-aminotridekan undecylenát, ktorý je schopný penetráciecez lipofilnú bariéru kože a hydrofilná část emulzného krému obsahuje 2-aminotridekan kyslýadipát. Přítomnost účinných látok v obidvoch fázach zaisťuje komplexný dezinfekčný, antimikrobi-álny a antimykotický účinok pracovného ochranného emulzného krému. Výhodou riešenia podlá vynálezu je kombinovaný povrchový i hlbkový dezinfekčný, anti-mikrobiálny a antimykotický účinok zabezpečujúci ochranu narušenej pokožky.The hydrophilic emulsion cream of the present invention solves these drawbacks by dissolving 2-aminotridecane undecylenate in the hydrophobic portion of the emulsion, which is capable of penetrating through the lipophilic skin barrier, and the hydrophilic portion of the emulsion cream contains 2-aminotridecane acid adipate. The presence of the active ingredients in both phases provides a comprehensive disinfectant, antimicrobial and antifungal effect of the protective protective emulsion cream. The advantage of the solution according to the invention is a combined surface and deep disinfectant, anti-microbial and antimycotic effect ensuring protection of the damaged skin.

Podstatou vynálezu je hydrofilný pracovný ochranný krém vyznačujúci sa tým, že v hydro-fóbnej časti obsahuje 2-aminotridekan undecylát v množstve od 0,25 do 0,50 % hmotnostnýchs výhodou 0,25 % hmotnostných a v hydrofilnéj časti emulzie 0,10 % hmotnostných až 0,50 ihmotnostných s výhodou 0,10 % hmotnostných·2-aminotridekan kyslý adipát.SUMMARY OF THE INVENTION The subject of the invention is a hydrophilic protective protective cream, characterized in that in the hydrophobic part, the 2-aminotridecane undecylate contains from 0.25 to 0.50% by weight, preferably 0.25% by weight and 0.10% by weight in the hydrophilic part of the emulsion. up to 0.50 wt%, preferably 0.10 wt%, 2-aminotridecane acid adipate.

Pracovný ochranný hydrofilný emulzný krém podlá vynálezu bol klinicky odskúšaný a vyka-zuje výrazné dezinfekčně, antimikrobiálne a antimykotické účinky.The working protective hydrophilic emulsion cream of the invention has been clinically tested and exhibits significant disinfection, antimicrobial and antifungal effects.

Uvedená kombinácia antimikrobiálnych látok bola odskúŠaná podlá britského liekopisu(B. P. Presservative Effectiveness Test 1980) s použitými kmeňmi: S. aureus ATCC 6 538This combination of antimicrobial agents was tested according to the British Pharmacopoeia (B. P. Presservative Effectiveness Test 1980) with the strains used: S. aureus ATCC 6 538

Ps. aeruginosa NTCC 675 C. albicans ATCC 10 231 A. niger ATCC 16 404. Výsledky ukazujú vo všetkých prípadoch zvolených mikroorganizmov výrazný pokles počtu jednotiek mikroorganizmov vo formulácii.Ps. aeruginosa NTCC 675 C. albicans ATCC 10 231 A. niger ATCC 16 404. The results show a significant decrease in the number of microorganism units in the formulation in all cases of selected microorganisms.

Stabilita hydrofilného krému bola skúšaná štandardným postupom pri obyčajnej teplote, +5 °c, +40 °C a piatich cykloch tuhnutia (topenia, ktoré simulujú kolísanie teploty počas skladovania). řThe stability of the hydrophilic cream was tested by standard procedures at ordinary temperature, + 5 ° C, + 40 ° C, and five solidification cycles (melts that simulate temperature fluctuations during storage). ř

Claims (2)

1. Hydrofilný emulzný krém vyznačujúci sa tým, že v hydrofóbnej časti obsahuje 2-aminotridekan undecylát v množstve od 0,25 do 0,50 % hmotnostných a v hydrofilnej časti emulzie 0,10 % hmotnostných až 0,50 % hmotnostných 2-aminotridekan kyslý adipát.Hydrophilic emulsion cream, characterized in that the hydrophobic portion contains 2-aminotridecane undecylate in an amount of 0.25 to 0.50% by weight and in the hydrophilic portion of the emulsion 0.10% by weight to 0.50% by weight 2-aminotridecane acid adipate . 2. Hydrofilný emulzný krém podlá bodu 1 vyznačujúci sa tým, a hydrofóbnou fázou je 71,65:22,35.2. The hydrophilic emulsion cream of claim 1, wherein the hydrophobic phase is 71.65: 22.35. že poměr medzi hydrofilnouthat the ratio between hydrophilic
CS872085A 1987-03-26 1987-03-26 Hydrophilic emulsion cream CS264721B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS872085A CS264721B1 (en) 1987-03-26 1987-03-26 Hydrophilic emulsion cream

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS872085A CS264721B1 (en) 1987-03-26 1987-03-26 Hydrophilic emulsion cream

Publications (2)

Publication Number Publication Date
CS208587A1 CS208587A1 (en) 1988-11-15
CS264721B1 true CS264721B1 (en) 1989-09-12

Family

ID=5356911

Family Applications (1)

Application Number Title Priority Date Filing Date
CS872085A CS264721B1 (en) 1987-03-26 1987-03-26 Hydrophilic emulsion cream

Country Status (1)

Country Link
CS (1) CS264721B1 (en)

Also Published As

Publication number Publication date
CS208587A1 (en) 1988-11-15

Similar Documents

Publication Publication Date Title
ES2237160T3 (en) TOPIC DERMIC ANTIMICROBIAL COMPOSITIONS.
CA2703299C (en) Anti-microbial composition
US12295366B2 (en) Preservation of personal care compositions
AU2023203406B2 (en) Emollient topical disinfectants
US4321277A (en) Germicidal use of compositions containing certain quaternary ammonium compounds
US20070249712A1 (en) Peracetic teat dip
US12478065B2 (en) Antimicrobial preservative compositions
EP0971583B1 (en) Disinfection method
US5441723A (en) Non-toxic hypocompatible biodegradable germicide
US5145663A (en) Biodegradable disinfectant containing anhydrous alcohol and propylene glycol
DE60220833T2 (en) DISINFECTANT FOR MEDICAL DEVICES AND SURFACE APPLICATIONS
US9308184B2 (en) Powder composition for disinfection of the teats of dairy animals
ES2582635T3 (en) Use of excipients as preservatives and pharmaceutical compositions containing them
US20060177518A1 (en) Peracetic teat dip
DD279408A5 (en) METHOD FOR PRODUCING A SUBSTANCE OR COMPOSITION THAT CAUSES OR ATTRIBUTES AT LEAST ONE-SINGLE LIVING
WO2016087630A1 (en) Biocidal composition with dual inmediate and remnant activity
DE60213361T2 (en) LIQUID ANTIMICROBIAL COMPOSITIONS
US6689394B2 (en) Removal of ectoparasites
CS264721B1 (en) Hydrophilic emulsion cream
ES2332978B1 (en) COLORED HEALTHY SKIN ANTISEPTICO BASED ON ISOPROPILIC ALCOHOL AND 2% CHLORHEXIDINE.
ES2324970B1 (en) HEALTHY, WOUND AND MUCOUS SKIN ANTISEPTICO.
KR20050077237A (en) Composition of sterilization use shampoo
CN111789795A (en) Hand sanitizer with liposome-encapsulated bactericidal component and preparation method thereof
CS260795B1 (en) Disinfectant tincture with dimethylbenzyl laurylammonium bromide
HK1146226B (en) Anti-microbial composition

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MK4A Patent expired

Effective date: 20020326